OPTIMER PHARMACEUTICALS INC Forms 3, 4 and 5: Warrants
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 18 rows, 18 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2009-03-04: Reporting owner SCHREIBER ALAIN; Form 4; Security Warrants to purchase common stock; Transaction P Open market or private purchase of non-derivative or derivative security.
- 2009-03-04: Reporting owner SCHREIBER ALAIN; Form 4; Security Warrants to purchase common stock; Transaction P Open market or private purchase of non-derivative or derivative security.
- 2009-03-04: Reporting owner SCHREIBER ALAIN; Form 4; Security Warrants to purchase common stock; Transaction P Open market or private purchase of non-derivative or derivative security.
- 2009-03-04: Reporting owner SCHREIBER ALAIN; Form 4; Security Warrants to purchase common stock; Transaction P Open market or private purchase of non-derivative or derivative security.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2009-03-04 | SCHREIBER ALAIN Director | 4 | Warrants to purchase common stock Derivative · Indirect · by ProQeust Investment II, L.P. | P Open market or private purchase of non-derivative or derivative security | +35,123 35,123 owned after | $10.93 exercise price | 2009-03-06 | |
| 2009-03-04 | SCHREIBER ALAIN Director | 4 | Warrants to purchase common stock Derivative · Indirect · by ProQuest Investments II Advisors Funds, L.P. | P Open market or private purchase of non-derivative or derivative security | +1,490 1,490 owned after | $10.93 exercise price | 2009-03-06 | |
| 2009-03-04 | SCHREIBER ALAIN Director | 4 | Warrants to purchase common stock Derivative · Indirect · by ProQuest Investments III, L.P. | P Open market or private purchase of non-derivative or derivative security | +18,307 18,307 owned after | $10.93 exercise price | 2009-03-06 | |
| 2009-03-04 | SCHREIBER ALAIN Director | 4 | Warrants to purchase common stock Derivative · Indirect · ProQeust Investments, IV, L.P. | P Open market or private purchase of non-derivative or derivative security | +36,613 36,613 owned after | $10.93 exercise price | 2009-03-06 | |
| 2007-02-14 | Che Tessie M Officer (SVP, Corporate Affairs) | 4 | Common Stock Warrant Derivative · Direct | X Exercise of in-the-money or at-the-money derivative security | −30,276 0 owned after | $1.08 exercise price | 2007-02-14 | |
| 2007-02-14 | Chang Michael N Director, Officer (President, CEO) | 4 | Common Stock Warrant Derivative · Indirect · By spouse | X Exercise of in-the-money or at-the-money derivative security | 0 owned after | $1.08 exercise price | 2007-02-14 | |
| 2007-02-14 | SCHREIBER ALAIN Director | 4 | Common Stock Warrant Derivative · Indirect · By ProQuest Investments II, L.P. | X Exercise of in-the-money or at-the-money derivative security | −98,387 0 owned after | $1.08 exercise price | 2007-02-14 | |
| 2007-02-14 | SCHREIBER ALAIN Director | 4 | Common Stock Warrant Derivative · Indirect · By ProQuest Investments II Advisors Fund, L.P. | X Exercise of in-the-money or at-the-money derivative security | −4,174 0 owned after | $1.08 exercise price | 2007-02-14 | |
| 2007-02-14 | Chow Joseph Director | 4 | Common Stock Warrant Derivative · Indirect · By SB Life Science Ventures I, L.P. | X Exercise of in-the-money or at-the-money derivative security | −25,640 0 owned after | $1.08 exercise price | 2007-02-14 | |
| 2007-02-14 | Lee Howard Director | 4 | Common Stock Warrant Derivative · Indirect · By Formosa Healthcare Investments, L.P. | X Exercise of in-the-money or at-the-money derivative security | −124,100 0 owned after | $1.08 exercise price | 2007-02-14 | |
| 2007-02-14 | Muenchbach Martin Director | 4 | Common Stock Warrant Derivative · Indirect · By BB Biotech Ventures II, L.P. | X Exercise of in-the-money or at-the-money derivative security | −256,406 0 owned after | $1.08 exercise price | 2007-02-14 | |
| 2007-02-08 holding as of filing | SCHREIBER ALAIN Director | 3 | Stock Warrant (right to buy) Derivative · Indirect · (m) | Holding | $1.08 exercise price | 2007-02-08 | ||
| 2007-02-08 holding as of filing | SCHREIBER ALAIN Director | 3 | Stock Warrant (right to buy) Derivative · Indirect · (m) | Holding | $1.08 exercise price | 2007-02-08 | ||
| 2007-02-08 holding as of filing | Muenchbach Martin Director | 3 | Stock Warrant (right to buy) Derivative · Indirect · (m) | Holding | $1.08 exercise price | 2007-02-08 | ||
| 2007-02-08 holding as of filing | Lee Howard Director | 3 | Stock Warrant (right to buy) Derivative · Indirect · (m) | Holding | $1.08 exercise price | 2007-02-08 | ||
| 2007-02-08 holding as of filing | Chow Joseph Director | 3 | Stock Warrant (right to buy) Derivative · Indirect · (m) | Holding | $1.08 exercise price | 2007-02-08 | ||
| 2007-02-08 holding as of filing | Che Tessie M Officer (Senior VP, Corporate Affairs) | 3 | Stock Warrant (right to buy) Derivative · Direct · (m) | Holding | $1.08 exercise price | 2007-02-08 | ||
| 2007-02-08 holding as of filing | Chang Michael N Director, Officer (President & CEO) | 3 | Stock Warrant (right to buy) Derivative · Indirect · (m) | Holding | $1.08 exercise price | 2007-02-08 |